Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-3791016
  • Global Auto-Injectors Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

  • Publish: October 2016 | Report Code: HME-3791016

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Auto-injectors refers to a medical device which is designed to deliver dose of a particular drug. They are designed in a spring loaded syringes which is easy to use and can be administered by patient itself without the need of trained personnel. Through auto injectors the patients can safely self-administered a drug at their home. The global auto-injectors market is anticipated to witness a CAGR of approx. 18.7% during the forecasted period 2016-2023. Auto-injectors market is primarily driven by the shift towards the self-administration of the extensively used therapies. Recently, auto-injectors have emerged as a significant class of devices, with the growing trend towards self-injection devices. Owing to their numerous benefits comprising of enhanced patient compliance, easy self-administration and reduced dosage errors, auto-injectors have gained significant popularity. Various pharmaceutical companies have collaborated with device respective marketed/pipeline drugs. Numerous drugs have been approved in combination with auto-injectors such as Plegridy, Trulicity, Simponi, Orencia, Actemra, Avonex, Repatha, Copaxone and Otrexup. An alarming increase in the prevalence of numerous food allergies and rheumatoid arthritis is significantly attributing towards the growth of the auto-injectors market globally. The global auto injector market is primarily driven by following factors:  

  • Increasing Prevalence of Chronic Diseases
  • Rising Demand for Medical Drug Injection Devices
  • Increasing Incidences of Anaphylaxis and Food Allergies
  • Enhanced Drug Delivery System & New Formulations





The key driver fueling growth in the global auto injector market is the increasing prevalence of chronic diseases such as diabetes and cancer along with rising demand for medical drug injection devices are also attributing towards the growth of the auto-injector market. In 2015, around $2.5 million individuals were living with cancer in the UK and this number is anticipated to increase to $4 million by 2030. Moreover, diabetes prevalence is also witnessing rapid growth. According to International Diabetes Federation, in 2015 approximately $415 million individuals were suffering from diabetes at global level and is expected to reach $642 million by 2040. The increasing prevalence of these diseases creates a wider scope for the auto-injectors in the upcoming scenarioThe demand for auto-injectors is expected to rise consistently as patients prefer these products owing to their ease of use, even during self-administration. The other key factor that has attributed significantly towards the growth of this market is increasing incidences of anaphylactic shock. Technological advancements in the auto-injectors and its rising demand from the developing economies are expected to create significant growth opportunities for the global market. However, high price of the auto-injectors and presence of substitute products such as general injections and oral tablets are hampering the growth of the global auto-injectors market.

Source: OBRC Analysis

The global auto injector’s market segments includes products, type, and material type, manufacturing design, distribution process and therapeutic applications. Products is further sub segmented into:

  • Fillable/Reusable Injectors
  • Prefilled/Disposable Auto-Injectors



 Type is further segmented into:

  • Single Chamber Pen Injectors
  • Dual Chamber Pen Injectors



Material is further segmented into:

  • Plastic Injectors
  • Glass Injectors



Manufacturing design is further segmented into:

  • Customized Auto-Injectors
  • Standardized Auto-Injectors



Distribution process is further segmented into:

  • Online pharmacies
  • Hospital Pharmacies
  • Drug Stores
  • Others





Therapeutic application is further segmented into:

  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others





The revenue for the above therapeutic application are specific to the auto injector market. However, the total revenue of these application in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up products, type, material, manufacturing design, distribution process and therapeutic applications segment.

Geographically, the global auto injectors market has been segmented on the basis of four major region, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is anticipated to accounts the largest market share fastest growing region from 2016 to 2023, due to the Technological developments in needle free technology and increasing incidences of diabetes are the key factors that are propelling the market growth in the region. According to International Diabetes Federation, in North America around $44.3 million people were suffering from diabetes in 2015 and this number is expected to reach $60.5 million by the end of 2040. Europe is also anticipated to witness significant demand during the projected period owing to rising preference of patients towards self-administered injections. Asia Pacific is anticipated to be the fastest growing region owing to favorable government initiatives coupled with supportive R&D initiatives in the region. The increasing prevalence of anaphylaxis and the rising healthcare expenditure for emergency medical applications are anticipated to attribute towards the growth of the Asia Pacific auto-injectors market.

The global auto-injectors market can be segmented on the basis of therapeutics applications, product, material, type and distribution sources. The overall market can be bifurcated on the basis of therapeutic applications including anaphylaxis, multiple sclerosis, rheumatoid arthritis and other therapeutic applications. Amongst the various therapeutic applications, anaphylaxis accounts for the largest market share in 2015 and it is anticipated to continue its dominance during the forecasted period. High prevalence of anaphylaxis has generated a substantial demand for auto injectors for administrating drugs to individuals suffering from this condition. According to AAFA (Asthma & Allergy Foundation), anaphylaxis is quite common in the US occurring in at least 1 in 50 individuals and more likely closer to 1 in 20 individuals. Anaphylaxis refers to a serious allergic reaction that occurs rapidly and may cause death. People with food allergies are at higher risk of anaphylaxis and therefore carry an epinephrine auto-injector which comprises life-saving medication in circumstances of an allergic reaction.  The market can further be segregated on the basis of product including fillable/reusable injectors and prefilled/disposable injectors. Among them, prefilled injectors dominates the global auto-injectors market due to the stability, convenience, safety and cost effectiveness of the injectors. The overall market can also be bifurcated on the basis of types comprising single chamber pen injectors and dual chamber pen injectors. In 2015, Dual chamber pen injector’s accounts for the largest market share owing to its time efficient technology and ease of use.

The major market players of the global auto injectors  market are:

  • ANTARES PHARMA INC
  • BECTON, DICKINSON & CO.
  • BIOGEN IDEC
  • NOVARTIS INTERNATIONAL AG
  • PFIZER INC.
  • OTHERS







These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching. Example November 2016 the Novartis Corporation had acquired Selexys Pharmaceuticals Corporation (SelG1) antibody for reduction of pain crises in sickle cell disease). Through this acquisition the company gets an advantage in hematology research and can provide a new advance development of a potential new treatment option for patients living with this debilitating condition ...Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

Why to buy the report:

This report will provide you:

  • Provide you the business strategies adopted by market player such as acquisition that is on November 2016 November 2016 the Novartis Corporation had acquired Selexys Pharmaceuticals Corporation (SelG1)
  • Provide in detail the different segments such as by products, type, and material, manufacturing design, distribution process and therapeutic applications which are affecting the global auto injector market.
  • Provide you the patent analysis of the auto injector market.
  • Identify, understand, and the strength, opportunities, challenges and threat of the auto injector market.
  • Provide revenues of major players of the market such as Novartis International AG, Pfizer Inc.
  • Provide you various the regulatory policies which are affecting the global auto injector market.







How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global auto injector market offers the longest chain of market segmentation covering major market segmentation based on products, type, and material, manufacturing design, distribution process and therapeutic application. The report tracks the major market trends in the global auto injector market such as growing trend towards self-injection devices and so on.  For each market segments covered in global auto injector market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the auto injector industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key Findings of the global auto injector market:

  • Rising prevalence of chronic diseases is fueling growth in global auto injector market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Anaphylaxis accounts for the largest market share among therapeutic applications segments due to high prevalence of anaphylaxis  which has generated a substantial demand for auto injectors.
  • Acquisition  is the key strategy adopted by the various market players of global auto injector market
  • Prefilled injectors segment in the product segment dominates the global auto-injectors market due to the stability, convenience, safety and cost effectiveness of the injectors.
 
 
 
 
 
 
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL   AUTO-INJECTORSS MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE &TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASES
3.1.2. RISING DEMAND FOR MEDICAL DRUG INJECTION DEVICES
3.1.3. INCREASING INCIDENCES OF ANAPHYLAXIS AND FOOD ALLERGIES
3.1.4. ENHANCED DRUG DELIVERY SYSTEM & NEW FORMULATIONS
3.1.5. GROWING NEED FOR TARGETED AND SUSTAINED DRUG DELIVERY
3.1.6.  RISING NEED FOR COST EFFICIENT DELIVERY OF EXPENSIVE MEDICATIONS
3.1.7.   RISING CONCERNS FOR THE HAZARDS RELATED WITH NEEDLE STICK INJURIES
3.1.8. INCREASING GERIATRIC POPULATION
3.1.9.  INCREASING HEALTHCARE EXPENDITURE 
3.2. MARKET RESTRAINTS
3.2.1. HIGHLY PRICED
3.3. MARKET OPPORTUNITIES
3.3.1.  TECHNOLOGICAL ADVANCEMENTS
3.3.2. INCREASING DEMAND FROM DEVELOPING ECONOMIES
3.3.3. INSURANCE REIMBURSEMENT BY GOVERNMENT
3.4.  MARKET CHALLENGES 
3.4.1.  DEMAND FOR SUBSTITUTE PRODUCTS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL   AUTO-INJECTORS S MARKET BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBA SINGLE CHAMBER PEN INJECTORS MARKET 
4.1.5.1.1. APPLICATIONS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL DUAL CHAMBER PEN INJECTORS MARKET 
4.1.5.2.1. APPLICATIONS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.2. GLOBAL   AUTO-INJECTORS S MARKET BY PRODUCT
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL FILLABLE/REUSABLE INJECTORS MARKET 
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL PREFILLED/DISPOSABLE AUTO-INJECTORS   MARKET 
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.3. GLOBAL   AUTO-INJECTORS S MARKET BY MATERIAL
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL PLASTIC INJECTORS   MARKET 
4.3.5.1.1. APPLICATIONS
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSION
4.3.5.2. GLOBAL  GLASS INJECTORS   MARKET 
4.3.5.2.1. APPLICATIONS
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSION
4.4. GLOBAL   AUTO-INJECTORS SMARKET BY MANUFACTURING DESIGN
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL CUSTOMIZED AUTO-INJECTORS MARKET 
4.4.5.1.1. APPLICATIONS
4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.1.5. KEY CONCLUSIONS
4.4.5.2. GLOBAL STANDARDIZED AUTO-INJECTORS MARKET
4.4.5.2.1. APPLICATIONS
4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.2.5. KEY CONCLUSIONS
4.5. GLOBAL   AUTO-INJECTORS SMARKET BY DISTRIBUTION SOURCES
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.4. OPPORTUNITY MATRIX
4.5.5. MARKET SEGMENTATION 
4.5.5.1. GLOBAL ONLINE PHARMACIES MARKET 
4.5.5.1.1. APPLICATIONS
4.5.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.1.5. KEY CONCLUSIONS
4.5.5.2. GLOBAL HOSPITAL PHARMACIES MARKET 
4.5.5.2.1. APPLICATIONS
4.5.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.2.5. KEY CONCLUSIONS
4.5.5.3. GLOBAL DRUG STORES MARKET 
4.5.5.3.1. APPLICATIONS
4.5.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.3.5. KEY CONCLUSIONS
4.5.5.4. GLOBAL OTHERS   MARKET 
4.5.5.4.1. APPLICATIONS
4.5.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.4.5. KEY CONCLUSIONS
4.6. GLOBAL   AUTO-INJECTORS SMARKET BY THERAPEUTIC APPLICATIONS
4.6.1. MARKET DEFINITION AND SCOPE
4.6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.6.4. OPPORTUNITY MATRIX
4.6.5. MARKET SEGMENTATION 
4.6.5.1. GLOBAL ANAPHYLAXIS     MARKET 
4.6.5.1.1. APPLICATIONS
4.6.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.6.5.1.5. KEY CONCLUSIONS
4.6.5.2. GLOBAL MULTIPLE SCLEROSIS  MARKET 
4.6.5.2.1. APPLICATIONS
4.6.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.6.5.2.5. KEY CONCLUSIONS
4.6.5.3. GLOBAL RHEUMATOID ARTHRITIS   MARKET 
4.6.5.3.1. APPLICATIONS
4.6.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.6.5.3.5. KEY CONCLUSIONS
4.6.5.4. GLOBAL OTHERS   MARKET 
4.6.5.4.1. APPLICATIONS
4.6.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.6.5.4.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION 
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GLOBAL   AUTO-INJECTORS SMARKET BY REGION 
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. ITALY 
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1.  ANTARES PHARMA INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION/FOCUS SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. AMEDRA PHARMACEUTICALS LLC
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION/FOCUS SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. BECTON, DICKINSON & CO
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION/FOCUS SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS 
7.4. BESPAK
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION/FOCUS SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS 
7.4.6. STRATEGIC ANALYSIS
7.5. BIOGEN IDEC
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION/FOCUS SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. CHANGZHOU DELFU TECHNOLOGY
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION/FOCUS SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. DALI MEDICAL DEVICES
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION/FOCUS SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. MYLAN N.V.
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION/FOCUS SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. NOVARTIS INTERNATIONAL AG
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION/FOCUS SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. OVAL MEDICAL TECHNOLOGIES
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION/FOCUS SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11.    OWEN MUMFORD
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION/FOCUS SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS 
7.11.6. STRATEGIC ANALYSIS
7.12.  PFIZER INC.
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION/FOCUS SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS 
7.12.6. STARTEGIC ANALYSIS
7.13. SCANDINAVIAN HEALTH LTD.
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION/FOCUS SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS 
7.13.6. STARTEGIC ANALYSIS
7.14. UNILIFE CORPORATION
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION/FOCUS SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS 
7.15. YPSOMED HOLDING AG
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION/FOCUS SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL   AUTO-INJECTORS SMARKET BY TYPE 2014-2023($ MILLION)
2. GLOBAL SINGLE CHAMBER PEN INJECTORSMARKET  BY GEOGRAPHY2014-2023($ MILLION)
3. GLOBAL DUAL CHAMBER PEN INJECTORS MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
4. GLOBAL   AUTO-INJECTORS SMARKET BY PRODUCT2014-2023($ MILLION)
5. GLOBAL FILLABLE/REUSABLE INJECTORS MARKET BY GEOGRAPHY 2014-2023($ MILLION)
6. GLOBAL  PREFILLED/DISPOSABLE AUTO-INJECTORS  MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
7. GLOBAL   AUTO-INJECTORS SMARKET BY MATERAIL 2014-2023($ MILLION)
8. GLOBAL PLASTIC INJECTORS    MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
9. GLOBAL  GLASS INJECTORS MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
10. GLOBAL   AUTO-INJECTORS SMARKET BY MANUFACTURING DESIGN 2014-2023($ MILLION)
11. GLOBAL CUSTOMIZED AUTO-INJECTORS  MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
12. GLOBAL STANDARDIZED AUTO-INJECTORS  MARKET  BY GEOGRAPHY 2014-2023($ MILLION)
13. GLOBAL   AUTO-INJECTORS SMARKET BY  DISTRIBUTION SOURCES 2014-2023($ MILLION)
14. GLOBAL ONLINE PHARMACIES   MARKET BY GEOGRAPHY 2014-2023($ MILLION)
15. GLOBAL  HOSPITAL PHARMACIES MARKET BY GEOGRAPHY 2014-2023($ MILLION)
16. GLOBAL   DRUG STORES  MARKET BY GEOGRAPHY 2014-2023($ MILLION)
17. GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023($ MILLION)
18. GLOBAL   AUTO-INJECTORS SMARKET BY  THERAPEUTIC APPLICATIONS 2014-2023($ MILLION)
19. GLOBAL ANAPHYLAXIS  MARKET BY GEOGRAPHY 2014-2023($ MILLION)
20. GLOBAL MULTIPLE SCLEROSIS MARKET BY GEOGRAPHY 2014-2023($ MILLION)
21. GLOBAL RHEUMATOID ARTHRITIS  MARKET BY GEOGRAPHY 2014-2023($ MILLION)
22. GLOBAL OTHERS   MARKET BY GEOGRAPHY 2014-2023($ MILLION)
23. NORTH AMERICA   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
24. EUROPE   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
25. ASIA PACIFIC   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
26. REST OF THE WORLD   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
 
LIST OF FIGURES
 
1. GLOBAL   AUTO-INJECTORS SMARKET BY FILLABLE/REUSABLE INJECTORS 2014-2023($ MILLION)
2. GLOBAL   AUTO-INJECTORS SMARKET BY PREFILLED/DISPOSABLE AUTO-INJECTORS   2014-2023 ($ MILLION)
3. GLOBAL   AUTO-INJECTORS SMARKET BY PLASTIC INJECTORS  2014-2023 ($ MILLION)
4. GLOBAL   AUTO-INJECTORS SMARKET BY GLASS INJECTORS   2014-2023 ($ MILLION)
5. GLOBAL   AUTO-INJECTORS SMARKET BY SINGLE CHAMBER PEN INJECTORS 2014-2023 ($ MILLION)
6. GLOBAL   AUTO-INJECTORS SMARKET BY  DUAL CHAMBER PEN INJECTORS2014-2023 ($ MILLION)
7. GLOBAL   AUTO-INJECTORS SMARKET BY CUSTOMIZED AUTO-INJECTORS  2014-2023 ($ MILLION)
8. GLOBAL   AUTO-INJECTORS SMARKET BY STANDARDIZED AUTO-INJECTORS 2014-2023 ($ MILLION)
9. GLOBAL   AUTO-INJECTORS SMARKET BY ONLINE PHARMACIES  2014-2023 ($ MILLION)
10. GLOBAL   AUTO-INJECTORS SMARKET BY HOSPITAL PHARMACIES  2014-2023 ($ MILLION)
11. GLOBAL   AUTO-INJECTORS SMARKET BY DRUG STORES   2014-2023 ($ MILLION)
12. GLOBAL   AUTO-INJECTORS SMARKET BY  OTHERS  2014-2023 ($ MILLION)
13. GLOBAL   AUTO-INJECTORS SMARKET BY ANAPHYLAXIS  2014-2023 ($ MILLION)
14. GLOBAL   AUTO-INJECTORS SMARKET BY MULTIPLE SCLEROSIS  2014-2023 ($ MILLION)
15. GLOBAL   AUTO-INJECTORS SMARKET BY RHEUMATOID ARTHRITIS  2014-2023 ($ MILLION)
16. GLOBAL   AUTO-INJECTORS SMARKET BY OTHERS   2014-2023 ($ MILLION)
17. UNITED STATES (U.S.)   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
18. CANADA   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
19. UNITED KINGDOM (UK)   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
20. FRANCE   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
21. GERMANY   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
22. SPAIN   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
23. ITALY   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
24. ROE   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
25. INDIA   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
26. CHINA   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
27. JAPAN   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
28. KOREA   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
29. AUSTRALIA   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
30. ROW APAC   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
31. LATIN AMERICA   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
32. MENA   AUTO-INJECTORS SMARKET2014-2023 ($MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion